VIEW MORE
The Nocturna Rosa Association of Malgrat is a non-profit organization that is dedicated, since 2010, to the organization of solidarity...
La Nocturna Rosa will finance the ADDAPTING project to investigate new therapeutic strategies for luminal breast cancer
Cesar Serrano - VHIO
VIEW MORE
Co-authored by César Serrano, a Medical Oncologist at the Vall d’Hebron University Hospital and Head of VHIO’s Sarcoma Translational Research...
Bridging the gap between foundational cancer biology and clinical oncology: mission possible
VIEW MORE
Daniela Silvia Bobos, representing Kaleido Ideas & Logistics, presented the check for 7,000€ to Dr. César Serrano, head of the...
The Kaleido Against Sarcoma initiative is supporting the SarcModel project for the third year in a row

Latest News

The Nocturna Rosa Association of Malgrat is a non-profit organization that is dedicated, since 2010, to the organization of solidarity...

La Nocturna Rosa will finance the ADDAPTING project to investigate new therapeutic strategies for luminal breast cancer
The Nocturna Rosa Association of Malgrat is a non-profit organization that is dedicated, since 2010, to the organization of solidarity...
Cesar Serrano - VHIO

Co-authored by César Serrano, a Medical Oncologist at the Vall d’Hebron University Hospital and Head of VHIO’s Sarcoma Translational Research...

Bridging the gap between foundational cancer biology and clinical oncology: mission possible
Co-authored by César Serrano, a Medical Oncologist at the Vall d’Hebron University Hospital and Head of VHIO’s Sarcoma Translational Research...

Daniela Silvia Bobos, representing Kaleido Ideas & Logistics, presented the check for 7,000€ to Dr. César Serrano, head of the...

The Kaleido Against Sarcoma initiative is supporting the SarcModel project for the third year in a row
Daniela Silvia Bobos, representing Kaleido Ideas & Logistics, presented the check for 7,000€ to Dr. César Serrano, head of the...
Grupo de Radiómica VHIO

Published in Cell Reports Medicine, results of a VHIO-led retrospective study demonstrate the potential of a novel, CT-based deep learning-driven...

SALSA: a new artificial intelligence tool for the automated and precise analysis of liver tumors
Published in Cell Reports Medicine, results of a VHIO-led retrospective study demonstrate the potential of a novel, CT-based deep learning-driven...

PRINCIPAL RESEARCHERS

Diseño sin título (16)
Cristina Saura
Breast Cancer & Melanoma Group

The main area of expertise of the Breast Cancer Group is clinical research focused on drug development and associated translational…

Dr. Elena Garralda UITM Caixa Research VHIO
Elena Garralda
Early Clinical Drug Development Group

We focus on proof-of-concept and proof-of-mechanism trials with targeted therapies, with particular emphasis on cell signaling, cancer stem cells, and…

Teresa Macarulla VHIO
Teresa Macarulla
Gastrointestinal and Endocrine Tumors Group

Our group continues to play an essential role in developing molecular therapies against GI malignancies. We make important contributions to…

VHIO Alena Gros
Alena Gros
Tumor Immunology and Immunotherapy Group

Our group focuses on better understanding the naturally occurring T-cell response to cancer and establishing ways to exploit these antitumor…

Events

Thursday 13 November 25 - 09:00 AM 2nd VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology
Friday 23 May 25 - 12:00 PM VHIO - CaixaResearch Scientific Seminars Series - With Dr. Mariam Jamal-Hanjani BSc MBBS PhD FRCP
Friday 6 June 25 - 08:30 AM 3rd Phd Day Vall d'Hebron
Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.